Empresa Bioblast Pharma Ltd Nasdaq
Acciones
IL0011319527
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Oren Hershkovitz
CEO | Chief Executive Officer | 47 | 16/11/19 |
Dror Mevorach
FOU | Founder | 68 | 01/01/09 |
Director of Finance/CFO | 47 | 01/01/16 | |
Chief Operating Officer | - | - | |
Sigal Arad
HRO | Human Resources Officer | - | - |
Iris Tavor
LAW | General Counsel | - | - |
Einat Galamidi
PRN | Corporate Officer/Principal | - | 22/02/22 |
Oren Elmaliah
AUD | Comptroller/Controller/Auditor | 40 | 01/02/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Shai Novik
CHM | Chairman | 58 | 01/01/14 |
Avri Havron
BRD | Director/Board Member | 76 | 01/01/14 |
Brian Schwartz
BRD | Director/Board Member | 52 | 01/12/20 |
Roger Pomerantz
BRD | Director/Board Member | 67 | 23/05/22 |
Gili Hart
BRD | Director/Board Member | 49 | 01/01/14 |
Andrew Singer
BRD | Director/Board Member | 53 | 17/04/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 18 811 781 | 15 198 104 ( 80,79 %) | 0 | 80,79 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,42 % | 115 mil M | |
+11,84 % | 106 mil M | |
-1,05 % | 21,96 mil M | |
-14,15 % | 21,84 mil M | |
-5,29 % | 19,21 mil M | |
-4,16 % | 18,08 mil M | |
-38,29 % | 17,71 mil M | |
+7,99 % | 14,32 mil M | |
+36,24 % | 12,42 mil M |